Sub-chronic Effects of 5-hydroxytryptophan on Mood and Emotional Processing in Healthy Volunteers
NCT01514409 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 33
Last updated 2012-01-23
Summary
5-hydroxytryptophan (5-HTP) is a nutritional supplement sold in many health food stores, and is taken in order to raise levels of serotonin in the brain. Serotonin is a neurotransmitter that is involved in the regulation of mood.
Previous research has assessed the effects of raising serotonin levels using tryptophan (the precursor of 5-HTP) and serotonergic antidepressants on emotional processing in healthy volunteers. However, to date there has been no human trial investigating the effects of 5-HTP on emotional processing in healthy volunteers.
Thus, the current study aims to assess the effects of 5-HTP, on emotional processing and mood in healthy volunteers.
Conditions
- Mood
Interventions
- DIETARY_SUPPLEMENT
-
5-Hydroxytryptophan
Thirty-three participants were randomly allocated in a double-blind manner to receive either 3x50mg capsules of 5-HTP or placebo (silica) for 14 days. 5-HTP is produced commercially by extraction from the seeds of the African plant griffonia simplicifolia.
- DIETARY_SUPPLEMENT
-
Pharmaceutical grade silica
Pharmaceutical grade silica was utilized as placebo
Sponsors & Collaborators
-
Northumbria University
lead OTHER
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- TRIPLE
- Model
- PARALLEL
Eligibility
- Min Age
- 18 Years
- Max Age
- 65 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2011-05-31
- Primary Completion
- 2011-08-31
- Completion
- 2011-08-31
Countries
- United Kingdom
Study Locations
More Related Trials
-
Placebo-controlled Trial of 5-hydroxytryptophan and Creatine for SSRI or SNRI Augmentation in Treatment Resistant Depression in Females
NCT02922725 ·Status: TERMINATED ·Phase: PHASE4
-
Mood, Serotonin and Social Interaction
NCT02051530 ·Status: COMPLETED ·Phase: EARLY_PHASE1
-
5-HTP and Creatine for Depression R33 Phase
NCT05895747 ·Status: RECRUITING ·Phase: PHASE2
-
Efficacy of Resveratrol in Depression
NCT03384329 ·Status: COMPLETED ·Phase: PHASE4
-
Pilot Study: Combining Nutritional Supplements With Standard Antidepressant to Treat Depression.
NCT02223299 ·Status: WITHDRAWN ·Phase: NA
-
Management Strategy for Mild to Moderate Major Depression: Combination of Rhodiola and Saffron Extracts.
NCT02981225 ·Status: COMPLETED
-
7T Amygdala and Citalopram Study
NCT06412315 ·Status: RECRUITING ·Phase: NA
-
Citalopram and Self Emotional Processing
NCT04169230 ·Status: UNKNOWN ·Phase: NA
-
Serotonin-receptor Agonism in Reward Processing
NCT05357547 ·Status: COMPLETED ·Phase: PHASE2
-
Mood Effects of Serotonin Agonists Extended
NCT03934710 ·Status: COMPLETED ·Phase: PHASE1
-
Analysis of Peripheral Serotonin Levels in a Control Cohort
NCT06910774 ·Status: COMPLETED
-
Simvastatin and Emotional Processing (OxSTEP)
NCT04973800 ·Status: COMPLETED ·Phase: NA
-
Investigating the Neuropsychological Effects of 5-HT2a Antagonism
NCT07022366 ·Status: RECRUITING ·Phase: NA
-
TC-5214 as add-on the Treatment of Major Depressive Disorder
NCT00692445 ·Status: COMPLETED ·Phase: PHASE2
-
REward Processing And Citalopram Study
NCT06017037 ·Status: UNKNOWN ·Phase: PHASE1/PHASE2
-
Drug Therapy to Treat Minor Depression
NCT00048815 ·Status: COMPLETED ·Phase: NA
-
Citalopram to Enhance Cognition in HD
NCT00271596 ·Status: COMPLETED ·Phase: PHASE2
-
Modulation of Visually Evoked Potentials by an Antidepressant
NCT00263133 ·Status: COMPLETED ·Phase: NA
-
PET Whole Body Distribution Studies Using [11C]CUMI
NCT01132872 ·Status: COMPLETED
-
Serotonergic Pharmacotherapy for Agitation of Dementia
NCT00009204 ·Status: COMPLETED ·Phase: PHASE3
-
Effects of Statin Medications on Mental Processes, Behavior, and Serotonin Levels
NCT00330980 ·Status: COMPLETED ·Phase: PHASE4
-
Wellbutrin XL Effects on SSRIs Induced Changes
NCT00456820 ·Status: COMPLETED ·Phase: PHASE4
-
Study In Patients With Depression Not Responding to Selective Serotonin Re-uptake Inhibitors
NCT00296517 ·Status: COMPLETED ·Phase: PHASE3
-
A 12-weeks Study to Evaluate Sulforaphane in the Treatment of Depression
NCT04246905 ·Status: UNKNOWN ·Phase: PHASE2
-
Sensoril(Ashwaganhda)for Bipolar Disorder
NCT00761761 ·Status: COMPLETED ·Phase: PHASE3